Randomized, Placebo‐Controlled Trial of the Cognitive Effect, Safety, and Tolerability of Oral Extended‐Release Oxybutynin in Cognitively Impaired Nursing Home Residents with Urge Urinary Incontinence

Abstract

Short-term treatment using oral extended-release oxybutynin 5 mg once daily was safe and well tolerated, with no delirium, in older female nursing home participants with mild to severe dementia. Future research should investigate different dosages and long-term treatment.